Home Programme » List of Posters

List of Posters

Poster
ID

Title / Presenter

P01

Phosphatase of Regenerating Liver-3 is an inducer of aerobic glycolysis in Multiple Myeloma cells
Pegah Abdollahi

P02

The role of protein tyrosine phosphatase oxidation in zebrafish caudal fin regeneration
Maaike Allers

P03

Regulation of the adipogenic differentiation of human mesenchymal stem cells by (-)-epigallocatechin-3-gallate via activation of protein phosphatase-2A and degradation of myosin phosphatase regulatory subunit
Bálint Bécsi

P04

Luciferase-based Screening for Inhibitors of Phosphatase Holoenzymes (LuSIPH)
Zander Claes

P05

The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active Site Catalytic Metals in PPP5C.
Brandon D'Arcy

P06

On the tumor suppressive role of PP2A-B56δ in hepatocellular carcinoma
Judit Domenech Omella

P07

Modulation of Phosphoprotein Phosphatase 1 complexes using bioportides: A novel approach for male contraception
Margarida Fardilha

P08

The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion
Gareth Fearnley

P09

New DUSP12 nuclear protein partners under conditions of genomic instability
Fabio Forti

P10

The PP2A carboxy-terminal tail: a challenge for antibody recognition
Ingrid Frohner

P11

Histone demethylases and transcriptional regulators Gis1 and Rph1 are the main functional targets of PP2A-Cdc55 during environmental stress
Gabriela Gerecova

P12

Investigating the role of phosphorylated Drp1 in the neurodegenerative Huntington’s disease.
Marvi Ghani

P13

Pseudophosphatase MK-STYX alters histone deacetylase 6 cytoplasmic localization, decreases its phosphorylation, and increases detyrosination of tubulin
Shantá Hinton

P14

New small-molecule inhibitors of the cancer-promoting phosphatase PRL-3
Andreas Hoffmann

P15

Regulation of cell metabolism by LAR, a receptor-type protein tyrosine phosphatase
Carys Howell

P16

Mutational analysis of the PP2A catalytic subunit carboxy terminus identifies residues required for TIPRL binding
Ana Amélia Sancez Iacia

P17

PP4 in cell cycle regulation
Zoltán Kármán

P18

Annexin A2 is a novel interacting partner of TIMAP in endothelial cells
Nikolett Király

P19

A mass-spectrometric approach based on randomized phosphopeptide libraries to study the sequence preference of protein phosphatases 1 and 2A
Thomas Kokot

P20

Interactions of protein phosphatase-1 catalytic subunit with small molecule inhibitors and activators assessed by different binding methods
Zoltán Kónya

P21

Heterozygous deletion of PTP1B in dendritic cells completely protects mice from the development of experimental autoimmune uveitis.
Samantha Le Sommer

P22

Glucose deprivation-induced ROS promotes RIPK1-dependent necrotic cell death by PP2A inactivation in cancer cells
Younghwan Lee

P23

Functional analysis of the PP1 regulator Inhibitor-2 using an inducible degron cell line
Sarah Lemaire

P24

An okadaic acid fragment analogue prevents nicotine-induced chemoresistance to cisplatin by recovering the impaired PP2A activity in NSCLC
Raquel López

P25

Investigation of the role of smoothelin-like protein 1 in hyperthyroidism
Evelin Major

P26

The tumor suppressive role of PPP2R4, encoding the PP2A activator PTPA, in KRAS mutant non-small cell lung cancer
Bob Meeusen

P27

Cardiac dysfunction in mice overexpressing both PP2A and PP5
Joachim Neumann

P28

Protein phosphatase 2A A-alpha regulates A-beta protein expression and stability
Caitlin O'Connor

P29

Characterization of PPP2R5D variant cell lines generated using CRISPR/CAS9 base editing technologies
Cinta Maria Papke

P30

Structural characterization PP2A inhibitor protein ARPP19, a predictive marker for acute myeloid leukemia relapse
Ulla Pentikäinen

P31

De novo mutations in specific PP2A subunit encoding genes, including PPP2CA, cause a (neuro)developmental disorder
Sara Reynhout

P32

In vitro protein-lipid interaction analysis of the Phosphatase of the Regenerating Liver-3 (PRL-3)
Pablo Rios-Munoz

P33

Phosphatases as regulators of heterochromatin establishment and maintenance
Raquel Sales

P34

Sulforaphane-mediated inhibition of SHP2 as a potential pharmacotherapy for Noonan syndrome
Joy Smith

P35

Dual-specificity phosphatase DUSP6 sustains tumourigenic properties of neuroblastoma cells in culture and in vivo 
Elliott Thompson

P36

Deletion of CaPpz1 protein phosphatase enhances the effects of oxidative stress in Candida albicans
Krisztina Szabó

P37

Exploring the effects of phosphorylation on protein Arginine methyltransferase 5 characteristics with molecular dynamics
István Tamás

P38

Role of protein phosphatase 2A B55α in angiogenesis 
Zsófia Thalwieser

P39

Cancerous protein phosphatase 2A inhibitor proteins - novel perspective for cancer therapy.
Chandan Thapa

P40

Activation of myosin phosphatase sensitizes cancer cells to chemotherapeutic drugs
Emese Tóth

P41

Photocaged PP1 disrupting peptides for temporal control of PP1 activity
Malgorzata Trebacz

P42

Luciferase-based protein-protein interaction assay in living cells revealed SET dimerization to be essential for association with PP2A-B56 complex
Shunya Tsuji

P43

Differences between PP2ACdc55 and PP2ARts1 holoenzyme biogenesis
Jiri Veis

P44

Isoform-specific requirement for a protein phosphatase and its regulating kinase for male fertility in mammals.
Srinivasan Vijayaraghavan

P45

Engineering phosphatases for discovery of non-active site inhibitors
Gregg Siegal

FEBS has twin commitments to high-quality publications and the promotion of molecular biosciences. As a charitable academic organization,
FEBS uses income from the journals to fund its diverse activities, including support for FEBS Advanced Courses.